LT - Farmacinės kompozicijos, apimančios aktivin-actRIIA antagonistus, ir jų panaudojimas išsėtinės mielomos prevencijai arba gydymui
EN - Pharmaceutical compositions comprising Activin-ActRIIA antagonists and use thereof in preventing or treating multiple myeloma
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 38/18 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
2120999 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
08725055.1 |
|
Date of filing the European patent application |
2008-02-01 |
| (97) |
Date of publication of the European application |
2009-11-25 |
| (45) |
Date of publication and mention of the grant of the patent |
2012-08-29
|
| (46) |
Date of publication of the claims translation |
2012-12-27
|
PCT application
| (86) |
Number |
PCT/US2008/001354 |
|
Date |
2008-02-01 |
PCT application publication
| (87) |
Number |
WO 2008/100384 |
|
Date |
2008-08-21 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
900580 P |
2007-02-09
|
US |
|
932762 P |
2007-05-31
|
US |
|
937365 P |
2007-06-26
|
US |
|
52807 P |
2007-10-25
|
US |
Inventors
| (72) |
KNOPF, John, US
SEEHRA, Jasbir, US
KUMAR, Ravindra, US
|
Grantee
| (73) |
Acceleron Pharma, Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Farmacinės kompozicijos, apimančios aktivin-actRIIA antagonistus, ir jų panaudojimas išsėtinės mielomos prevencijai arba gydymui |
| |
Pharmaceutical compositions comprising Activin-ActRIIA antagonists and use thereof in preventing or treating multiple myeloma |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2026-01-13 |
19 |
347.00
EUR
|
Next renewal fee
|
2027-02-01 |
